HomeCompareBICSX vs MRK

BICSX vs MRK: Dividend Comparison 2026

BICSX yields 2.59% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $33.2K in total portfolio value
10 years
BICSX
BICSX
● Live price
2.59%
Share price
$12.34
Annual div
$0.32
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.6K
Annual income
$306.66
Full BICSX calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — BICSX vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBICSXMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BICSX + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BICSX pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BICSX
Annual income on $10K today (after 15% tax)
$220.48/yr
After 10yr DRIP, annual income (after tax)
$260.66/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,067.75/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BICSX + MRK for your $10,000?

BICSX: 50%MRK: 50%
100% MRK50/50100% BICSX
Portfolio after 10yr
$40.2K
Annual income
$5,052.40/yr
Blended yield
12.58%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

BICSX
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BICSX buys
0
MRK buys
0
No recent congressional trades found for BICSX or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBICSXMRK
Forward yield2.59%2.76%
Annual dividend / share$0.32$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$23.6K$56.8K
Annual income after 10y$306.66$9,798.13
Total dividends collected$2.8K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BICSX vs MRK ($10,000, DRIP)

YearBICSX PortfolioBICSX Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,959$259.39$11,206$366.19$247.00MRK
2$11,992$265.68$12,650$502.35$658.00MRK
3$13,103$271.70$14,407$694.19$1.3KMRK
4$14,298$277.45$16,585$967.82$2.3KMRK
5$15,582$282.94$19,342$1,363.89$3.8KMRK
6$16,961$288.18$22,913$1,947.19$6.0KMRK
7$18,441$293.16$27,662$2,823.89$9.2KMRK
8$20,030$297.89$34,159$4,173.35$14.1KMRK
9$21,734$302.39$43,337$6,308.80$21.6KMRK
10$23,563$306.66$56,776$9,798.13$33.2KMRK

BICSX vs MRK: Complete Analysis 2026

BICSXStock

The adviser utilizes two strategies and under normal circumstances expects to invest approximately 50% of its total assets in each strategy. One strategy focuses on investments in commodity-linked derivatives. To meet coverage and collateral requirements associated with these derivative investments, and to invest excess cash, the fund holds a portion of its portfolio in investment-grade short-term fixed-income securities. The other strategy focuses on equity investments in commodity-related companies, including, but not limited to, companies operating in the mining, energy and agricultural sectors.

Full BICSX Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this BICSX vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BICSX vs SCHDBICSX vs JEPIBICSX vs OBICSX vs KOBICSX vs MAINBICSX vs JNJBICSX vs ABBVBICSX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.